Navigation Links
UT study: Chemical in antibacterial soaps may harm nursing babies
Date:6/27/2013

KNOXVILLEA mother's prolonged use of antibacterial soaps containing the chemical triclocarban may harm nursing babies, according to a recent study from the University of Tennessee, Knoxville.

The study, which was conducted on rats, showed that exposure to the compound may reduce the survival rates of babies.

Rebekah Kennedy, a UT graduate student pursuing a dual master's degree in public health and nutrition, and Jiangang Chen, an assistant professor in the UT Department of Public Health, presented the results this month at the Endocrine Society's 95th Annual Meeting and Expo in San Francisco. Kennedy was the study's lead author.

Triclocarban, a bactericide, is found primarily in antibacterial bar soaps.

The researchers noted that they were not condemning the use of antibacterial soaps.

"People have to weigh their own risks and decide what would be the best route," Kennedy said. "There's always a time and place for antibacterial bar soaps, such as in health care settings where the chance of infection and transmission is high. For the average person, antibacterial soap is no more effective than regular soap."

Chen conducted an earlier study that examined how prolonged exposure to triclocarban affected growth of sex organs in adult male rats. Kennedy decided to go a step further and look into how it would affect baby rats in the womb and during nursing.

Humans are exposed to triclocarban through skin absorption. Research shows that based on how the compound is biotransformed, oral exposure in rats is similar to dermal exposure for humans, Kennedy said.

During Kennedy's research, pregnant rats fed with triclocarban through food had similar blood concentrations compared to human blood concentrations after a 15-minute shower using antibacterial soap.

The study found that triclocarban did not affect the post-birth survival rate of baby rats exposed to the compound in the womb. But baby
'/>"/>

Contact: Lola Alapo
lalapo@utk.edu
865-974-3993
University of Tennessee at Knoxville
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study: Pedometer program helps motivate participants to sit less, move more
2. Study: MicroRNA cooperation mutes breast cancer oncogenes
3. Study: Environmental policies matter for growing megacities
4. Study: Widespread test-and-treat HIV policies could increase dangerous drug resistance
5. Study: Probiotics reduce stress-induced intestinal flare-ups
6. Study: Antibiotics are unique assassins
7. International study: Excess dietary salt may drive the development of autoimmune diseases
8. Influenza study: Meet virus new enemy
9. Study: Resveratrol shows promise to protect hearing, cognition
10. Nature Methods study: Using light to control cell clustering
11. Study: Viral reactivation a likely link between stress and heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... NEW YORK (DECEMBER 30, 2008)The Bronx Zoo-based Wildlife Conservation Society ... region in South America have paid off in the form ... by the Government of Argentina. ... which became official earlier this month, protects half a million ...
... E or a combination of the supplements had a similar ... supplements, according to data from a randomized controlled trial in ... the National Cancer Institute. Epidemiological studies have suggested ... and thus antioxidants, may have a lower risk of cancer. ...
... COLUMBUS, Ohio Researchers at The Ohio State University ... in leukemia and lung cancer is also important in ... mainly children. The study shows that immature ... mature, and that the molecule is nearly missing in ...
Cached Biology News:A happy new year for penguins 2Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial 2Study links molecule to muscle maturation, muscle cancer 2
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 ... in Personalized Medicine, is excited to announce the ... Testing to Optimize the Management of Pain”. , ... at Medscape.com for the next year. The focus ... how to recognize inadequate pain treatments, integrate appropriate ...
(Date:3/4/2015)... March 04, 2015 Follow us ... one of the fastest growing technologies in the life ... subcellular visualization is driving growth in nucleic acid detection ... understanding of gene expressions will continue to benefit the ... in fields ranging from pharma, biotech, food & beverage ...
(Date:3/3/2015)... TORONTO, March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... therapeutics and molecular diagnostics that target the underlying mechanisms ... and seventh-month period ended December 31, 2014. ... year end from May 31 to December 31. As ... reporting today are for the quarter and the seven ...
Breaking Biology Technology:Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... release of it,s advanced nutritional supplement, Caplex, ... unique patent pending formulation created by an ... cancer patients a comprehensive source of the most ... results accumulated from medical research. Impressive changes in ...
... of Standards and Technology (NIST) have demonstrated a new ... intersection while keeping their cool. Ten million times cooler ... described in a forthcoming paper in Physical Review ... technology to build a large-scale quantum computer using ions ...
... Sinobiopharma Pharmaceutical Group (OTC Bulletin Board: SNBP) ... Yan Tan as Director of Marketing.Ms. Tan joins ... served as a China-based Unit Marketing Director for ... to Organon, Ms. Tan held senior marketing management ...
Cached Biology Technology:Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option 2X marks the spot: Ions coldly go through NIST trap junction 2Sinobiopharma, Inc. Appoints New Director of Marketing 2
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
Yersinia pestis...
Biology Products: